TrademarkDir
S
DEAD

Serial Number

97535581

Owner

Siren Biotechnology, Inc.

First Use Date

Sep 9, 2020

Filing Date

Aug 4, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

S Trademark

Serial Number: 97535581

S is a trademark filed by Siren Biotechnology, Inc. on August 4, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Siren Biotechnology, Inc. (17 trademarks)

953 Indiana Street
San Francisco, CA 94107

Entity Type: 03

Trademark Details

Filing Date

August 4, 2022

Registration Date

Not Registered

First Use Anywhere

September 9, 2020

First Use in Commerce

May 17, 2023

Published for Opposition

June 27, 2023

Goods & Services

Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 20, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 20, 2024 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 1, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 1, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 1, 2024 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 6, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 6, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
May 6, 2024 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 2, 2024 EXRA
STATEMENT OF USE PROCESSING COMPLETE
May 1, 2024 SUPC
SOU EXTENSION 1 GRANTED
May 1, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 29, 2024 AITU
USE AMENDMENT FILED
Apr 7, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 7, 2024 EISU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Apr 7, 2024 TPEX
NOTICE OF REVIVAL - E-MAILED
Apr 7, 2024 NREV
PETITION TO REVIVE-GRANTED
Apr 7, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Apr 7, 2024 PROA
TEAS PETITION TO REVIVE RECEIVED
Apr 7, 2024 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 25, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 25, 2024 ABN6
SOU EXTENSION 1 FILED
Feb 22, 2024 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 22, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 27, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 27, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 7, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
May 22, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 22, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
May 22, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 22, 2023 CNEA
ASSIGNED TO EXAMINER
May 15, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 26, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2022 NWOS
NEW APPLICATION ENTERED
Aug 8, 2022 NWAP

Related Trademarks

More from this Owner

SIREN

SIREN

Trademark logo

Serial #99736946

THE MARK CONSISTS OF OUR COMPANY NAME ‘SIREN BIOTECHNOLOGY’ WITH A STYLIZED DESIGN ELEMENT IN THE LETTER "E" OF SIREN, AND A STYLIZED FONT logo

THE MARK CONSISTS OF OUR COMPANY NAME ‘SIREN BIOTECHNOLOGY’ WITH A STYLIZED DESIGN ELEMENT IN THE LETTER "E" OF SIREN, AND A STYLIZED FONT

CURING CANCER UNIVERSALLY

CURING CANCER UNIVERSALLY

CURING CANCER UNIVERSALLY

CURING CANCER UNIVERSALLY

GENE THERAPY OF THE FUTURE

GENE THERAPY OF THE FUTURE